Format

Send to

Choose Destination
Lancet Infect Dis. 2009 Mar;9(3):197-202. doi: 10.1016/S1473-3099(09)70045-3.

Reflections on the white plague.

Author information

1
Centre for Infectious Diseases and International Health, University College London Medical School, UCL Windeyer Institute of Medical Sciences, London, UK. a.zumla@ucl.ac.uk

Abstract

Tuberculosis continues to be one of the leading causes of morbidity and mortality from infectious disease worldwide. When WHO declared tuberculosis a global emergency in 1993, the initial response from the international community was sluggish and inadequate. A resurgence of the disease, the emergence of multidrug-resistant and extensively drug-resistant strains, and the detrimental effect of the concurrent tuberculosis and HIV/AIDS epidemics on national control programmes in sub-Saharan Africa have all occurred despite the availability of effective combination treatment regimens. On the positive side, funding agencies and donor governments are at long last taking a serious interest in investing in tuberculosis research priorities defined by the Stop TB Partnership. Although this investment introduces optimism for eventual control of the White Plague, past failures remind us not to be complacent.

PMID:
19246023
DOI:
10.1016/S1473-3099(09)70045-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center